http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2531996-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6d6b0a9721d7b7ca7d5f368df0f3658
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
filingDate 2010-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a235fb48597513476e29223ed0a0923e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf0d53fd04ae07fb0bf2d7eac5517081
publicationDate 2015-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2531996-T3
titleOfInvention Humanized antibodies against human IL-22RA
abstract A humanized antibody that binds to human IL-22RA, comprising: a) a heavy chain variable domain comprising H-CDR1, H-CDR2, and H-CDR3 consisting of amino acid sequences of SEQ ID NO: 1 , 2 and 3, respectively; and b) a light chain variable domain comprising L-CDR1, L-CDR2, and L-CDR3 consisting of amino acid sequences of SEQ ID NO: 4, 5 and 6, respectively, or consisting of amino acid sequences of SEQ ID NO: 4, 5 and 7, respectively.
priorityDate 2009-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10029
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10359
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10359
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID116379
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24293
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11886
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10029
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID767864
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10366
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10366
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3588
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447566935
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65046
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID28908
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11886
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID237310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454552299
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID28412
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID619391
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID692307
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16155

Total number of triples: 53.